Oct. 14, 2003 — Complexed prostate-specific antigen (cPSA) as a single test improved specificity over total PSA, according to the results of a prospective study published in the November issue of the ...

Instead of waiting days or even weeks for the result of a prostate-specific antigen (PSA) test, physicians and their patients can now have the information in minutes, thanks to a novel device recently ...

The PSA test is an imperfect way to screen men for prostate cancer. But until recently, it was seen as the best option available. The test measures the amount of prostate specific antigen, or PSA, in ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

MIAMI, Feb. 01, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s point-of-care Sangia Total Prostate ...

Please provide your email address to receive an email when new articles are posted on . A novel blood test was more accurate than PSA screening for identifying patients with high-risk prostate cancer, ...